Literature DB >> 15507606

Cell cycle arrest in G2 induces human immunodeficiency virus type 1 transcriptional activation through histone acetylation and recruitment of CBP, NF-kappaB, and c-Jun to the long terminal repeat promoter.

Sylvain Thierry1, Vincent Marechal, Michelle Rosenzwajg, Michèle Sabbah, Gérard Redeuilh, Jean-Claude Nicolas, Joël Gozlan.   

Abstract

In human immunodeficiency virus type 1 (HIV-1)-infected cells, a cell cycle arrest in G(2) increases viral expression and may represent a strategy for the virus to optimize its expression. In latently infected cells, balance between viral silencing and reactivation relies on the nucleosomal organization of the integrated long terminal repeat (LTR). It is shown here that nucleosome nuc-1, which is located downstream of the TATA box, is specifically modified when latently infected cells are arrested in G(2) by chemical inducers. Notably, histones H3 and H4 are hyperacetylated, and this modification is associated with an increased LTR-driven transcription. nuc-1 hyperacetylation is also associated with the recruitment of histone acetyltransferase CBP and transcription factors NF-kappaB and c-Jun. NF-kappaB and/or c-Jun binding to the LTR in G(2)-arrested cells appears to be required for CBP recruitment as well as for nuc-1 remodeling and viral reactivation.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15507606      PMCID: PMC525107          DOI: 10.1128/JVI.78.22.12198-12206.2004

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  35 in total

1.  Transcription factor binding sites downstream of the human immunodeficiency virus type 1 transcription start site are important for virus infectivity.

Authors:  C Van Lint; C A Amella; S Emiliani; M John; T Jie; E Verdin
Journal:  J Virol       Date:  1997-08       Impact factor: 5.103

2.  HIV-1 Vpr increases viral expression by manipulation of the cell cycle: a mechanism for selection of Vpr in vivo.

Authors:  W C Goh; M E Rogel; C M Kinsey; S F Michael; P N Fultz; M A Nowak; B H Hahn; M Emerman
Journal:  Nat Med       Date:  1998-01       Impact factor: 53.440

3.  Transcriptional activation of the integrated chromatin-associated human immunodeficiency virus type 1 promoter.

Authors:  A El Kharroubi; G Piras; R Zensen; M A Martin
Journal:  Mol Cell Biol       Date:  1998-05       Impact factor: 4.272

4.  Modulation of cytokine-induced HIV gene expression by competitive binding of transcription factors to the coactivator p300.

Authors:  M O Hottiger; L K Felzien; G J Nabel
Journal:  EMBO J       Date:  1998-06-01       Impact factor: 11.598

5.  Vpr stimulates viral expression and induces cell killing in human immunodeficiency virus type 1-infected dividing Jurkat T cells.

Authors:  X J Yao; A J Mouland; R A Subbramanian; J Forget; N Rougeau; D Bergeron; E A Cohen
Journal:  J Virol       Date:  1998-06       Impact factor: 5.103

6.  Human immunodeficiency virus type 1 induction mediated by genistein is linked to cell cycle arrest in G2.

Authors:  J Gozlan; J L Lathey; S A Spector
Journal:  J Virol       Date:  1998-10       Impact factor: 5.103

7.  Activation of integrated provirus requires histone acetyltransferase. p300 and P/CAF are coactivators for HIV-1 Tat.

Authors:  M Benkirane; R F Chun; H Xiao; V V Ogryzko; B H Howard; Y Nakatani; K T Jeang
Journal:  J Biol Chem       Date:  1998-09-18       Impact factor: 5.157

8.  Mutations in the tat gene are responsible for human immunodeficiency virus type 1 postintegration latency in the U1 cell line.

Authors:  S Emiliani; W Fischle; M Ott; C Van Lint; C A Amella; E Verdin
Journal:  J Virol       Date:  1998-02       Impact factor: 5.103

9.  Effect of pentoxifylline on radiation-induced G2-phase delay and radiosensitivity of human colon and cervical cancer cells.

Authors:  Y X Li; K Weber-Johnson; L Q Sun; N Paschoud; R O Mirimanoff; P A Coucke
Journal:  Radiat Res       Date:  1998-04       Impact factor: 2.841

10.  HIV-1 tat transactivator recruits p300 and CREB-binding protein histone acetyltransferases to the viral promoter.

Authors:  G Marzio; M Tyagi; M I Gutierrez; M Giacca
Journal:  Proc Natl Acad Sci U S A       Date:  1998-11-10       Impact factor: 11.205

View more
  30 in total

Review 1.  Translation initiation of the HIV-1 mRNA.

Authors:  Théophile Ohlmann; Chloé Mengardi; Marcelo López-Lastra
Journal:  Translation (Austin)       Date:  2014-10-31

Review 2.  Histone deacetylase inhibitors for purging HIV-1 from the latent reservoir.

Authors:  Shay Matalon; Thomas A Rasmussen; Charles A Dinarello
Journal:  Mol Med       Date:  2011-03-15       Impact factor: 6.354

3.  The histone deacetylase inhibitor ITF2357 decreases surface CXCR4 and CCR5 expression on CD4(+) T-cells and monocytes and is superior to valproic acid for latent HIV-1 expression in vitro.

Authors:  Shay Matalon; Brent E Palmer; Marcel F Nold; Antonio Furlan; Afework Kassu; Gianluca Fossati; Paolo Mascagni; Charles A Dinarello
Journal:  J Acquir Immune Defic Syndr       Date:  2010-05-01       Impact factor: 3.731

Review 4.  Molecular control of HIV-1 postintegration latency: implications for the development of new therapeutic strategies.

Authors:  Laurence Colin; Carine Van Lint
Journal:  Retrovirology       Date:  2009-12-04       Impact factor: 4.602

Review 5.  Molecular mechanisms of HIV-1 persistence in the monocyte-macrophage lineage.

Authors:  Valentin Le Douce; Georges Herbein; Olivier Rohr; Christian Schwartz
Journal:  Retrovirology       Date:  2010-04-09       Impact factor: 4.602

Review 6.  Manipulation of the host protein acetylation network by human immunodeficiency virus type 1.

Authors:  Mark Y Jeng; Ibraheem Ali; Melanie Ott
Journal:  Crit Rev Biochem Mol Biol       Date:  2015-09-02       Impact factor: 8.250

7.  p21(WAF1) gene promoter is epigenetically silenced by CTIP2 and SUV39H1.

Authors:  T Cherrier; S Suzanne; L Redel; M Calao; C Marban; B Samah; R Mukerjee; C Schwartz; G Gras; B E Sawaya; S L Zeichner; D Aunis; C Van Lint; O Rohr
Journal:  Oncogene       Date:  2009-07-06       Impact factor: 9.867

8.  Inhibition of HIV-1 gene expression by Ciclopirox and Deferiprone, drugs that prevent hypusination of eukaryotic initiation factor 5A.

Authors:  Mainul Hoque; Hartmut M Hanauske-Abel; Paul Palumbo; Deepti Saxena; Darlene D'Alliessi Gandolfi; Myung Hee Park; Tsafi Pe'ery; Michael B Mathews
Journal:  Retrovirology       Date:  2009-10-13       Impact factor: 4.602

9.  Mechanism of HIV-1 Tat RNA translation and its activation by the Tat protein.

Authors:  Nicolas Charnay; Roland Ivanyi-Nagy; Ricardo Soto-Rifo; Théophile Ohlmann; Marcelo López-Lastra; Jean-Luc Darlix
Journal:  Retrovirology       Date:  2009-08-11       Impact factor: 4.602

10.  The 5'-untranslated region of the mouse mammary tumor virus mRNA exhibits cap-independent translation initiation.

Authors:  Maricarmen Vallejos; Pablo Ramdohr; Fernando Valiente-Echeverría; Karla Tapia; Felipe E Rodriguez; Fernando Lowy; J Pablo Huidobro-Toro; John A Dangerfield; Marcelo López-Lastra
Journal:  Nucleic Acids Res       Date:  2009-11-04       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.